Blueshift Asset Management’s NEVRO CORP. NVRO Stock Holding History

Blueshift Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,799	Closed	-$808K	–	918
2020 Q3	$808K	Sell	5,799 -2,496	-30%	-$333K	0.11%	245
2020 Q2	$991K	Buy	+8,295	New	+$984K	0.16%	184
2019 Q2	–	Sell	-4,838	Closed	-$302K	–	1003
2019 Q1	$302K	Buy	+4,838	New	+$227K	0.04%	530

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Blueshift Asset Management's NVRO Position: Q4 2020 in Review

Blueshift Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 5,799 shares — an estimated $808K sold.

Blueshift Asset Management first reported a position in NVRO in Q1 2019 and held it in 3 quarters. The position peaked at $991K in Q2 2020. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

Blueshift Asset Management reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
Blueshift Asset Management sold 5,799 NEVRO CORP. shares in Q4 2020, an estimated $808K.
Blueshift Asset Management first reported a position in NEVRO CORP. in Q1 2019 and held it in 3 quarters.
Blueshift Asset Management's NEVRO CORP. position peaked at $991K in Q2 2020.
226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Blueshift Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.